Gunn B A, Ohashi D K, Gaydos C A, Holt E S
J Clin Microbiol. 1977 Jun;5(6):650-5. doi: 10.1128/jcm.5.6.650-655.1977.
Sheep blood agar containing 23.75 microgram of sulfamethoxazole and 1.25 microgram of trimethoprim (SXT-BA) per ml was compared with conventional sheep blood agar (SBA) for isolating group A and B streptococci from throat cultures. This selective medium allowed much better recovery of group A and B streptococci and suppressed the growth of the normal flora, including "viridans" streptococci. In an initial study of 700 throat cultures, SXT-BA recovered 42% more group A and 49% more group B streptococci than did SBA. When SXT-BA was introduced into the routine microbiology laboratory and used by a number of medical technologists. SXT-BA recovered 28% more group A and 37% more group B streptococci than did SBA. In addition, the selective medium inhibited 83% of the non-group A and B streptococci that were recovered by SBA.
将每毫升含23.75微克磺胺甲恶唑和1.25微克甲氧苄啶的绵羊血琼脂(SXT - BA)与传统绵羊血琼脂(SBA)进行比较,以从咽喉培养物中分离A组和B组链球菌。这种选择性培养基能更好地分离出A组和B组链球菌,并抑制包括“草绿色”链球菌在内的正常菌群生长。在对700份咽喉培养物的初步研究中,SXT - BA分离出的A组链球菌比SBA多42%,B组链球菌比SBA多49%。当SXT - BA引入常规微生物实验室并由多名医学技术人员使用时,SXT - BA分离出的A组链球菌比SBA多28%,B组链球菌比SBA多37%。此外,这种选择性培养基抑制了SBA分离出的83%的非A组和B组链球菌。